Skip to main content

Clinical Trial Results

Search

Dr. Jeffrey Berger and Dr. Arzu Kalayci Discuss: ACTIV-4A: P2y12 Inhibitors in Noncritically Ill Hospitalized Patients With Covid-19

Disclosures: TBD